Fox Business - The Power to Prosper
Search Site

Abbott Laboratories

Despite volatility, Trinity Industries a way to gain from rail industry?

FBN’s Charles Payne, Stifel Nicolaus Portfolio Manager Chad Morganlander and Penn Financial Group founder Matt McCall on the outlook for Trinity Industries.

Read More

  1. Sell in May and go away?

    BlackRock chief investment strategist Russ Koesterich and Bianco Research president Jim Bianco on the state of the markets.

  2. Where should investors put their money to work?

    STA Wealth Management Chief Strategist Lance Roberts, USAA Investments V.P. John Toohey and Athena Advisor Services’ Dan Stecich on the outlook for the markets.

  3. Abbott Laboratories 1Q earnings

    Earnings HQ: FBN’s Jo Ling Kent breaks down Abbott Laboratories ’ first-quarter earnings report.

  4. Abbott Beats Profit Forecast, But Sales Lag

    Abbott Laboratories Inc reported better-than-expected quarterly earnings, but sales came in slightly below Wall Street expectations.The company on Wednesday said it ...

  5. Stocks to watch: MSFT, ABT

    Glenmede Director of Investment Strategy Jason Pride, Janney Capital Markets Technical Research Director Dan Wantrobski and Altimus Capital Director of Portfolio Management Chris Gersch on the stocks to boost investors’ portfolios.

  6. Novartis CEO Reshapes Firm For 'Brutal' New World

    Novartis Chief Executive Joe Jimenez is taking a hard look at the drugmaker's smaller businesses as he reshapes the company for what he expects to be a "brutal" new ...

  7. Dan Loeb Takes Stakes In BlackBerry, T-Mobile

    Third Point, headed by billionaire fund manager Dan Loeb, has put more money into struggling mobile device makers. According to a 13-f filing released late Friday by...

  8. Abbott Misses Top Line Views in the Fourth Quarter

    Abbott Laboratories Inc reported weaker-than-expected fourth-quarter revenue, hurt by the stronger dollar and an overseas sales disruption last summer of its baby fo...

  9. AbbVie beats forecast as Humira sales surge

    AbbVie Inc on Friday reported stronger-than-expected results for the third quarter, as booming sales of its Humira arthritis treatment and Synthroid thyroid replacem...

  10. Detecting Malaria Using an Electric Vibe

    Hundreds of thousands of children die from malaria each year with about half of the world's population at risk of the disease at any given time, but new research has...

  11. Abbott Laboratories Reports Higher Quarterly Profits

    Abbott Laboratories reported better than expected quarterly earnings despite disrupted sales of its infant formulas in China, helped by cost cuts and lower taxes.The...

  12. Pharmaceutical Industry Expected To Collect Billions From Obamacare

    Despite the technical difficulties and the government shutdown, the Affordable Care Act has launched in most states with others soon to follow.Primary beneficiaries ...

  1. UK Trade Minister talks taxes

    UK Min. of State for Trade & Investment Lord Ian Livingston on the country’s plan to attract U.S. and foreign business.

  2. Treasury takes aim at corporate inversion

    FBN’s Liz MacDonald on deal stocks under pressure as the U.S. announces stricter tax rules.

  3. Political implications of the AbbVie-Shire deal

    Chapwood Investments’ Ed Butowsky and The Wall Street Journal Editorial Board’s Mary Kissel discuss the significance of AbbVie’s purchase of Ireland’s Shire.

  4. Abbott Laboratories 2Q earnings beat expectations

    Earnings HQ: FBN’s Adam Shapiro breaks down U.S. Bancorp’s second-quarter earnings report.

  5. Stocks to watch: CVS, ABT

    Kanaly Trust Chairman Drew Kanaly, Royal Oak Financial Group Managing Partner Matt Jehn and SFG Alternatives CIO Larry Shover on the opportunities in the markets for investors.

  6. Stocks to watch: KMI, ABT

    Glenmede Director of Investment Strategy Jason Pride, Wall Financial Group’s Michael Wall and founder Mark Sebastian on where the opportunities are for investors.

  7. Stocks to watch: GOOGL, DOW

    Rosenthal Wealth Management Group President Larry Rosenthal, Platinum Partners President Uri Landesman and Tethys Partners Chief Market Strategist Bob Iaccino on the markets.

‹ Prev12345Next ›
Freebase CC-BY
Source: Abbott Laboratories on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL